Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Fibrosis 2Peripheral Nervous System Diseases 1Pain 1Lymphedema 1Breast Neoplasms, Male 1Breast Cancer Female 1

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tumor Burden 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Female × Pentoxifylline × Breast × Clear all
NCT06176339 2024-03-15

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Mansoura University

Phase 2 Unknown
70 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡